Loading clinical trials...
Loading clinical trials...
Study of Adaptive Radiotherapy for High-grade Glioma Based on Interfraction Magnetic Resonance Imaging (MRI)
The changes of target and organs at risk in patients with high-grade glioma during concurrent chemoradiotherapy were evaluated by MRI image between radiotherapy fractions.
To prospectively evaluate the changes of target organs and risk organs in patients with high-grade glioma during concurrent chemoradiotherapy.The related factors causing this change are discussed.The relationship between changes and patient survival was analyzed.A predictive model was established to provide individualized adaptive radiotherapy for patients.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
West China Hospital
Chengdu, Sichuan, China
Start Date
January 1, 2024
Primary Completion Date
December 1, 2025
Completion Date
September 30, 2026
Last Updated
January 11, 2024
60
ESTIMATED participants
adaptive radiotherapy
DEVICE
Lead Sponsor
West China Hospital
NCT06763965
NCT05873946
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04730349